With regulatory bodies driving an increasing focus on environmental monitoring (EM) and contamination control strategy (CCS), pharmaceutical quality control labs are turning to alternative microbiological methods to improve processes, seeking to improve quality of results as well as achieve operational efficiencies. Innovative products featuring new technologies, such as artificial intelligence (AI), are emerging to help address these challenges. Understanding how the products are developed, the data used, and performance is critical for the implementation of these technologies into routine use.
Explore how AI-powered automation technology, like the APAS® Independence, is empowering EM programs to increase throughput, reduce operator subjectivity, and maintain regulatory compliance.
Click here for more information and to register
